Ghadah B. Alanazi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ghadah B. Alanazi has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Ahmed R. Alibrahim
Endocrinology and Metabolism, King Abdulaziz Medical City Riyadh, Riyadh, SAU
1 shared publication - Aida Aldughaither
Department of Family Medicine, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia
1 shared publication - Awad Alshahrani
King Abdullah International Medical Research Center, Riyadh, Riyadh Region, Saudi Arabia
1 shared publication - Fatemah Saleh Bin Saleh
Ministry of National Guard Health Affairs, King Abdulaziz Medical City, Riyadh, Kingdom of Saudi Arabia
1 shared publication - Moeber Mohammed Mahzari
College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
1 shared publication - Weam S. Alharbi
Department of Family Medicine, Ministry of Health, Riyadh, Saudi Arabia
1 shared publication
Latest Publications
- Open Access
- 26 December 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (52) , e46758
Lipid metabolism in type 1 and type 2 diabetes: A comparative cross-sectional study
Types 1 and 2 diabetes mellitus (T1DM and T2DM, respectively) are chronic conditions with distinct pathophysiological mechanisms and clinical manifestations. Dyslipidemia is a common complication in both types, contributing to increased cardiovascular risk. This study aimed to compare the demographic and laboratory characteristics of patients with T1DM and T2DM in Saudi Arabia. We conducted 2 different studies both are retrospective cross-sectional studies that involved 409 T2DM and 509 T1DM patients, respectively. Data were collected from electronic medical records. Clinical characteristics, including diabetes duration, body mass index, hemoglobin A1C levels, and lipid profiles, were analyzed. Statistical comparisons were conducted to identify significant differences between the 2 groups. Patients with T2DM were older (mean age, 58.93 years) than those with T1DM (mean age, 26.15 years). Additionally, substantial demographic differences were observed between the 2 groups. Compared with patients with T2DM, who had hemoglobin A1C levels between 7% to 9%, patients with T1DM had worse glycemic control, with 55.8% of them having such values. Patients with T2DM were more likely to have obesity (63.6%) than those with T1DM (21.8%). Compared with patients with T2DM, those with T1DM had lower triglyceride levels but higher mean low-density lipoprotein, high-density lipoprotein, and total cholesterol levels. A considerably larger proportion of individuals with T2DM had aberrant triglyceride and low high-density lipoprotein levels, indicating a higher incidence of dyslipidemia. Patients with T1DM and T2DM have different clinical characteristics and lipid abnormalities. Patients with T2DM are at higher risk of dyslipidemia and related cardiovascular complications. To reduce cardiovascular risk in patients with diabetes, customized therapies that concentrate on lipid management and glycemic control are necessary. To manage dyslipidemia, further studies are necessary to investigate the underlying mechanisms and develop efficient treatment plans.
- 26 December 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (52) , e46758
Open AccessLipid metabolism in type 1 and type 2 diabetes: A comparative cross-sectional study
Types 1 and 2 diabetes mellitus (T1DM and T2DM, respectively) are chronic conditions with distinct pathophysiological mechanisms and clinical manifestations. Dyslipidemia is a common complication in both types, contributing to increased cardiovascular risk. This study aimed to compare the demographic and laboratory characteristics of patients with T1DM and T2DM in Saudi Arabia. We conducted 2 different studies both are retrospective cross-sectional studies that involved 409 T2DM and 509 T1DM patients, respectively. Data were collected from electronic medical records. Clinical characteristics, including diabetes duration, body mass index, hemoglobin A1C levels, and lipid profiles, were analyzed. Statistical comparisons were conducted to identify significant differences between the 2 groups. Patients with T2DM were older (mean age, 58.93 years) than those with T1DM (mean age, 26.15 years). Additionally, substantial demographic differences were observed between the 2 groups. Compared with patients with T2DM, who had hemoglobin A1C levels between 7% to 9%, patients with T1DM had worse glycemic control, with 55.8% of them having such values. Patients with T2DM were more likely to have obesity (63.6%) than those with T1DM (21.8%). Compared with patients with T2DM, those with T1DM had lower triglyceride levels but higher mean low-density lipoprotein, high-density lipoprotein, and total cholesterol levels. A considerably larger proportion of individuals with T2DM had aberrant triglyceride and low high-density lipoprotein levels, indicating a higher incidence of dyslipidemia. Patients with T1DM and T2DM have different clinical characteristics and lipid abnormalities. Patients with T2DM are at higher risk of dyslipidemia and related cardiovascular complications. To reduce cardiovascular risk in patients with diabetes, customized therapies that concentrate on lipid management and glycemic control are necessary. To manage dyslipidemia, further studies are necessary to investigate the underlying mechanisms and develop efficient treatment plans.